These are the sources and citations used to research References. This bibliography was generated on Cite This For Me on

  • Journal

    Fisher, N. D., Jan Danser, A., Nussberger, J., Dole, W. P. and Hollenberg, N. K.

    Renal and Hormonal Responses to Direct Renin Inhibition With Aliskiren in Healthy Humans

    2008 - Circulation

    In-text: (Fisher et al., 2008)

    Your Bibliography: Fisher, N., Jan Danser, A., Nussberger, J., Dole, W. and Hollenberg, N., 2008. Renal and Hormonal Responses to Direct Renin Inhibition With Aliskiren in Healthy Humans. Circulation, 117(25), pp.3199-3205.

  • Journal

    Gandhi, S., Srinivasan, B. and Akarte, A. S.

    Aliskiren improves insulin resistance and ameliorates diabetic renal vascular complications in STZ-induced diabetic rats

    2012 - Journal of the Renin-Angiotensin-Aldosterone System

    In-text: (Gandhi, Srinivasan and Akarte, 2012)

    Your Bibliography: Gandhi, S., Srinivasan, B. and Akarte, A., 2012. Aliskiren improves insulin resistance and ameliorates diabetic renal vascular complications in STZ-induced diabetic rats. Journal of the Renin-Angiotensin-Aldosterone System, 14(1), pp.3-13.

  • Journal

    Gheorghiade, M., Bohm, M., Greene, S., Fonarow, G., Lewis, E., Zannad, F., Solomon, S., Baschiera, F., Botha, J., Hua, T., Gimpelewicz, C., Jaumont, X., Lesogor, A. and Maggioni, A.

    Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial

    2013 - JAMA

    In-text: (Gheorghiade et al., 2013)

    Your Bibliography: Gheorghiade, M., Bohm, M., Greene, S., Fonarow, G., Lewis, E., Zannad, F., Solomon, S., Baschiera, F., Botha, J., Hua, T., Gimpelewicz, C., Jaumont, X., Lesogor, A. and Maggioni, A., 2013. Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial. JAMA, 309, pp.1125-1135.

  • Journal

    Jamerson, K., Weber, M. A., Bakris, G. L., Dahlöf, B., Pitt, B., Shi, V., Hester, A., Gupte, J., Gatlin, M. and Velazquez, E. J.

    Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients

    2008 - New England Journal of Medicine

    In-text: (Jamerson et al., 2008)

    Your Bibliography: Jamerson, K., Weber, M., Bakris, G., Dahlöf, B., Pitt, B., Shi, V., Hester, A., Gupte, J., Gatlin, M. and Velazquez, E., 2008. Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients. New England Journal of Medicine, 359(23), pp.2417-2428.

  • Journal

    Kallergis, E. M., Manios, E. G., Kanoupakis, E. M., Mavrakis, H. E., Arfanakis, D. A., Maliaraki, N. E., Lathourakis, C. E., Chlouverakis, G. I. and Vardas, P. E.

    Extracellular Matrix Alterations in Patients With Paroxysmal and Persistent Atrial Fibrillation

    2008 - Journal of the American College of Cardiology

    In-text: (Kallergis et al., 2008)

    Your Bibliography: Kallergis, E., Manios, E., Kanoupakis, E., Mavrakis, H., Arfanakis, D., Maliaraki, N., Lathourakis, C., Chlouverakis, G. and Vardas, P., 2008. Extracellular Matrix Alterations in Patients With Paroxysmal and Persistent Atrial Fibrillation. Journal of the American College of Cardiology, 52(3), pp.211-215.

  • Journal

    Krum, H. and Maggioni, A.

    Renin Inhibitors in Chronic Heart Failure: The Aliskiren Observation of Heart Failure Treatment Study in Context

    2010 - Clinical Cardiology

    In-text: (Krum and Maggioni, 2010)

    Your Bibliography: Krum, H. and Maggioni, A., 2010. Renin Inhibitors in Chronic Heart Failure: The Aliskiren Observation of Heart Failure Treatment Study in Context. Clinical Cardiology, 33(9), pp.536-541.

  • Journal

    Kuriyama, S., Yokoyama, K., Hara, Y., Sugano, N., Yokoo, T. and Hosoya, T.

    Effect of aliskiren in chronic kidney disease patients with refractory hypertension undergoing hemodialysis: a randomized controlled multicenter study

    2013 - Clinical and Experimental Nephrology

    In-text: (Kuriyama et al., 2013)

    Your Bibliography: Kuriyama, S., Yokoyama, K., Hara, Y., Sugano, N., Yokoo, T. and Hosoya, T., 2013. Effect of aliskiren in chronic kidney disease patients with refractory hypertension undergoing hemodialysis: a randomized controlled multicenter study. Clinical and Experimental Nephrology, 18(5), pp.821-830.

  • Journal

    Mahfoz, A. M., El-Latif, H. A. A., Ahmed, L. A., Hassanein, N. M. and Shoka, A. A.

    Anti-diabetic and renoprotective effects of aliskiren in streptozotocin-induced diabetic nephropathy in female rats

    2016 - Naunyn-Schmiedeberg's Archives of Pharmacology

    In-text: (Mahfoz et al., 2016)

    Your Bibliography: Mahfoz, A., El-Latif, H., Ahmed, L., Hassanein, N. and Shoka, A., 2016. Anti-diabetic and renoprotective effects of aliskiren in streptozotocin-induced diabetic nephropathy in female rats. Naunyn-Schmiedeberg's Archives of Pharmacology, 389(12), pp.1315-1324.

  • Journal

    McMurray, J. J., Pitt, B., Latini, R., Maggioni, A. P., Solomon, S. D., Keefe, D. L., Ford, J., Verma, A. and Lewsey, J.

    Effects of the Oral Direct Renin Inhibitor Aliskiren in Patients With Symptomatic Heart Failure

    2008 - Circulation: Heart Failure

    In-text: (McMurray et al., 2008)

    Your Bibliography: McMurray, J., Pitt, B., Latini, R., Maggioni, A., Solomon, S., Keefe, D., Ford, J., Verma, A. and Lewsey, J., 2008. Effects of the Oral Direct Renin Inhibitor Aliskiren in Patients With Symptomatic Heart Failure. Circulation: Heart Failure, 1(1), pp.17-24.

  • Journal

    Morisawa, N., Sugano, N., Yamakawa, T., Kuriyama, S. and Yokoo, T.

    Successful long-term effects of direct renin inhibitor aliskiren in a patient with atherosclerotic renovascular hypertension

    2017 - CEN Case Reports

    In-text: (Morisawa et al., 2017)

    Your Bibliography: Morisawa, N., Sugano, N., Yamakawa, T., Kuriyama, S. and Yokoo, T., 2017. Successful long-term effects of direct renin inhibitor aliskiren in a patient with atherosclerotic renovascular hypertension. CEN Case Reports, 6(1), pp.66-73.

  • Journal

    Neuman, R. B., Bloom, H. L., Shukrullah, I., Darrow, L. A., Kleinbaum, D., Jones, D. P. and Dudley, S. C.

    Oxidative Stress Markers Are Associated with Persistent Atrial Fibrillation

    2007 - Clinical Chemistry

    In-text: (Neuman et al., 2007)

    Your Bibliography: Neuman, R., Bloom, H., Shukrullah, I., Darrow, L., Kleinbaum, D., Jones, D. and Dudley, S., 2007. Oxidative Stress Markers Are Associated with Persistent Atrial Fibrillation. Clinical Chemistry, 53(9), pp.1652-1657.

  • Journal

    Ribeiro-Oliveira Jr, A., Nogueira, A., Pereira, R., Boas, W., Dos Santos, R. and Simões e Silva, A.

    The renin-angiotensin system and diabetes: an update

    2008 - Vascular Health Risk Management

    In-text: (Ribeiro-Oliveira Jr et al., 2008)

    Your Bibliography: Ribeiro-Oliveira Jr, A., Nogueira, A., Pereira, R., Boas, W., Dos Santos, R. and Simões e Silva, A., 2008. The renin-angiotensin system and diabetes: an update. Vascular Health Risk Management, 4(4), pp.787-803.

  • Journal

    Santos, S. H. S., Fernandes, L. R., Mario, E. G., Ferreira, A. V. M., Porto, L. C. J., Alvarez-Leite, J. I., Botion, L. M., Bader, M., Alenina, N. and Santos, R. A. S.

    Mas Deficiency in FVB/N Mice Produces Marked Changes in Lipid and Glycemic Metabolism

    2007 - Diabetes

    In-text: (Santos et al., 2007)

    Your Bibliography: Santos, S., Fernandes, L., Mario, E., Ferreira, A., Porto, L., Alvarez-Leite, J., Botion, L., Bader, M., Alenina, N. and Santos, R., 2007. Mas Deficiency in FVB/N Mice Produces Marked Changes in Lipid and Glycemic Metabolism. Diabetes, 57(2), pp.340-347.

  • Journal

    Solomon, S. D., Appelbaum, E., Manning, W. J., Verma, A., Berglund, T., Lukashevich, V., Cherif Papst, C., Smith, B. A. and Dahlof, B.

    Effect of the Direct Renin Inhibitor Aliskiren, the Angiotensin Receptor Blocker Losartan, or Both on Left Ventricular Mass in Patients With Hypertension and Left Ventricular Hypertrophy

    2009 - Circulation

    In-text: (Solomon et al., 2009)

    Your Bibliography: Solomon, S., Appelbaum, E., Manning, W., Verma, A., Berglund, T., Lukashevich, V., Cherif Papst, C., Smith, B. and Dahlof, B., 2009. Effect of the Direct Renin Inhibitor Aliskiren, the Angiotensin Receptor Blocker Losartan, or Both on Left Ventricular Mass in Patients With Hypertension and Left Ventricular Hypertrophy. Circulation, 119(4), pp.530-537.

  • Journal

    Takei, Y., Ichikawa, M. and Kijima, Y.

    Oral direct renin inhibitor aliskiren reduces in vivo oxidative stress and serum matrix metalloproteinase-2 levels in patients with permanent atrial fibrillation

    2015 - Journal of Arrhythmia

    In-text: (Takei, Ichikawa and Kijima, 2015)

    Your Bibliography: Takei, Y., Ichikawa, M. and Kijima, Y., 2015. Oral direct renin inhibitor aliskiren reduces in vivo oxidative stress and serum matrix metalloproteinase-2 levels in patients with permanent atrial fibrillation. Journal of Arrhythmia, 31(2), pp.76-77.

Click here to start building your own bibliography
Keep on Citing!
Cite This For Me:
The Easiest Tool to Create your Bibliographies Online
Join Us!

Save Time and Improve Your Marks with Cite This For Me

10,587 students joined last month!

  • ✔ Save your bibliographies for longer
  • ✔ Quick and accurate citation program
  • ✔ Save time when referencing
  • ✔ Make your student life easy and fun
  • ✔ Pay only once with our Forever plan
  • ✔ Use plagiarism checker
  • ✔ Create and edit multiple bibliographies
Join